Mazumdar Claire
Chief Executive Officer · 34 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-10 | BCAX | Bicara Therapeutics Inc. | Sale | 9,972 | $28.42 | $283,367.34 | filing |
| 2026-07-10 | BCAX | Bicara Therapeutics Inc. | Option exercise | 10,000 | $3.79 | $37,898.00 | filing |
| 2026-07-10 | BCAX | Bicara Therapeutics Inc. | Sale | 28 | $29.68 | $831.04 | filing |
| 2026-05-18 | BCAX | Bicara Therapeutics Inc. | Sale | 12,022 | $19.96 | $239,981.96 | filing |
| 2026-05-18 | BCAX | Bicara Therapeutics Inc. | Sale | 2,978 | $20.35 | $60,596.64 | filing |
| 2026-05-18 | BCAX | Bicara Therapeutics Inc. | Option exercise | 15,000 | $3.79 | $56,847.00 | filing |
| 2026-04-20 | BCAX | Bicara Therapeutics Inc. | Sale | 15,000 | $23.61 | $354,145.50 | filing |
| 2026-04-20 | BCAX | Bicara Therapeutics Inc. | Option exercise | 15,000 | $3.79 | $56,847.00 | filing |
| 2026-04-16 | BCAX | Bicara Therapeutics Inc. | Option exercise | 7,080 | $5.45 | $38,612.20 | filing |
| 2026-04-16 | BCAX | Bicara Therapeutics Inc. | Option exercise | 8,226 | $4.44 | $36,497.94 | filing |
| 2026-04-16 | BCAX | Bicara Therapeutics Inc. | Option exercise | 7,454 | $3.79 | $28,249.17 | filing |
| 2026-03-20 | BCAX | Bicara Therapeutics Inc. | Sale | 1,596 | $18.95 | $30,246.27 | filing |
| 2026-03-20 | BCAX | Bicara Therapeutics Inc. | Option exercise | 1,596 | $3.79 | $6,048.52 | filing |
| 2026-03-19 | BCAX | Bicara Therapeutics Inc. | Sale | 6,905 | $18.78 | $129,704.90 | filing |
| 2026-03-19 | BCAX | Bicara Therapeutics Inc. | Option exercise | 6,905 | $3.79 | $26,168.57 | filing |
| 2026-03-18 | BCAX | Bicara Therapeutics Inc. | Sale | 6,499 | $18.84 | $122,414.51 | filing |
| 2026-03-18 | BCAX | Bicara Therapeutics Inc. | Option exercise | 6,499 | $3.79 | $24,629.91 | filing |
| 2026-03-09 | BCAX | Bicara Therapeutics Inc. | Sale | 36,766 | $19.17 | $704,657.16 | filing |
| 2026-03-09 | BCAX | Bicara Therapeutics Inc. | Option exercise | 36,766 | $3.79 | $139,335.79 | filing |
| 2026-03-06 | BCAX | Bicara Therapeutics Inc. | Sale | 3,817 | $18.75 | $71,571.80 | filing |
| 2026-03-06 | BCAX | Bicara Therapeutics Inc. | Option exercise | 3,817 | $3.79 | $14,465.67 | filing |
| 2026-03-05 | BCAX | Bicara Therapeutics Inc. | Sale | 1,786 | $18.74 | $33,464.10 | filing |
| 2026-03-05 | BCAX | Bicara Therapeutics Inc. | Option exercise | 1,786 | $3.79 | $6,768.58 | filing |
| 2026-03-04 | BCAX | Bicara Therapeutics Inc. | Sale | 2,631 | $18.73 | $49,288.63 | filing |
| 2026-03-04 | BCAX | Bicara Therapeutics Inc. | Option exercise | 2,631 | $3.79 | $9,970.96 | filing |
| 2025-12-16 | BCAX | Bicara Therapeutics Inc. | Option exercise | 29,500 | $5.45 | $160,884.15 | filing |
| 2025-11-24 | BCAX | Bicara Therapeutics Inc. | Sale | 41,163 | $18.86 | $776,428.85 | filing |
| 2025-11-24 | BCAX | Bicara Therapeutics Inc. | Option exercise | 41,163 | $3.79 | $155,999.54 | filing |
| 2025-10-16 | BCAX | Bicara Therapeutics Inc. | Sale | 24,103 | $18.83 | $453,760.67 | filing |
| 2025-10-16 | BCAX | Bicara Therapeutics Inc. | Option exercise | 24,103 | $3.79 | $91,345.55 | filing |
| 2025-10-15 | BCAX | Bicara Therapeutics Inc. | Sale | 13,289 | $18.84 | $250,391.34 | filing |
| 2025-10-15 | BCAX | Bicara Therapeutics Inc. | Option exercise | 13,289 | $3.79 | $50,362.65 | filing |
| 2025-10-13 | BCAX | Bicara Therapeutics Inc. | Sale | 11,445 | $18.92 | $216,545.12 | filing |
| 2025-10-13 | BCAX | Bicara Therapeutics Inc. | Option exercise | 11,445 | $3.79 | $43,374.26 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.